tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Exelixis (EXEL)
NASDAQ:EXEL
US Market
EXEL
Exelixis
RESEARCH TOOLSreports
Advertisement

Exelixis (EXEL) Stock News & Sentiment

Compare
3,081 Followers
Optimistic Buy Rating for Exelixis Amid Promising Phase III Trial Results for Zanzalintinib
Premium
Ratings
Optimistic Buy Rating for Exelixis Amid Promising Phase III Trial Results for Zanzalintinib
5d ago
EXEL
Novo Nordisk, Grab, Vistra, Exelixis, Dropbox: Trending by Analysts
Premium
Weekend Updates
Novo Nordisk, Grab, Vistra, Exelixis, Dropbox: Trending by Analysts
15d ago
DBX
NVO
Exelixis: Strong Growth Potential with Promising Zanzalintinib Outlook and Attractive Investment Opportunity
Premium
Ratings
Exelixis: Strong Growth Potential with Promising Zanzalintinib Outlook and Attractive Investment Opportunity
18d ago
EXEL
Exelixis Advances Phase 1 Study of XL309 for Advanced Solid Tumors
Premium
Company Announcements
Exelixis Advances Phase 1 Study of XL309 for Advanced Solid Tumors
28d ago
EXEL
Exelixis Advances in Neuroendocrine Tumor Treatment with New Clinical Trial
Premium
Company Announcements
Exelixis Advances in Neuroendocrine Tumor Treatment with New Clinical Trial
28d ago
EXEL
Exelixis’s Promising Growth Potential and Strategic Expansion Justify Buy Rating
Premium
Ratings
Exelixis’s Promising Growth Potential and Strategic Expansion Justify Buy Rating
1M ago
EXEL
Exelixis Announces New Executive VP for R&D
Premium
Company Announcements
Exelixis Announces New Executive VP for R&D
1M ago
8K
EXEL
More EXEL News >

EXEL News on the Web

Novo Nordisk, Grab, Vistra, Exelixis, Dropbox: Trending by Analysts
TipRanks News
Neutral
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
Zacks
Neutral
Do Options Traders Know Something About Exelixis Stock We Don't?
Zacks
Neutral
Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?
Zacks
Neutral
Why Is Exelixis (EXEL) Up 3.8% Since Last Earnings Report?
Zacks
Neutral
Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?
Zacks
Neutral
Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?
Zacks
Neutral
Will EXEL's Share Repurchase Program Boost Value for Investors?
Zacks
Neutral

News Score - Last 7 Days

Neutral
EXEL
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EXEL’s Media Buzz Sentiment?
1 articles about EXEL were published this week. In an average week, 1 articles are published.
    What is EXEL’s weekly average amount of articles?
    In an average week, 1 articles about EXEL are published.
      What is EXEL’s News Sentiment?
      100% of articles about EXEL were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        ANGOAngioDynamics
        AMRXAmneal Pharmaceuticals
        PFEPfizer
        OCCOrthocell Ltd
        CRLCharles River Labs
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing